The more recently discovered member of the γc cytokine family, IL-21, has also been explored as an anti-cancer treatment and IL-21 monotherapy of thymoma and melanoma in mice has shown to result in improved CD8+ T cell-mediated anti-tumor responses with augmented long-term survival (193, 202–204). This evidence concerns the gene CD8A and melanoma.